Journal Information
Vol. 111. Issue 7.
Pages 627 (September 2020)
Vol. 111. Issue 7.
Pages 627 (September 2020)
Letter to the Editor
DOI: 10.1016/j.adengl.2020.06.002
Open Access
Chilblain and Acral Purpuric Lesions in COVID-19
Chilblain y lesiones purpúricas acrales en COVID-19
Visits
...
V. Wiwanitkit
Departamento de Medicina Comunitaria, DY Patil University, Pune, India
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor:

I would like to share ideas on the report on “Lesiones pernióticas y acrales en España durante el confinamiento por COVID: análisis retrospectivo de 12 casos” with a great interest.1 El Romaní et al. noted that Como conclusión, este sorprendente cuadro clínico es atípico porque ha aparecido durante el clima cálido, no asociado con la perniosis común y, aunque tiene una relación temporal con la pandemia de COVID, en ninguno de los pacientes hay evidencia demostrable de infección por COVID-19 actual o pasada.1 “Regarding the present report by Romaní et al.,1 it should performed additional study to rule out other possible causes of skin lesion such as other concurrent virus infection. In fact, Chilblain and Acral Purpuric Lesions are new emerging dermatological conditions that are reported from many countries although there is a lack of report from tropical zone.2,3 The new evidences show that there might be an association with COVID-19. The identification of immunoglobulin to SARSCoV2 in some patients becomes the clue for further study on dermatopathophysiology of chilblain and acral purpuric lesions in COVID-19.4

References
[1]
J. Romaní, E. Baselga, O. Mitjà, N. Riera-Martí, P. Garbayo, A. Vicente, et al.
Chilblain and acral purpuric lesions in spain during COVID confinement: retrospective analysis of 12 cases.
Actas Dermosifiliogr, (2020),
[2]
E.E. Freeman, D.E. McMahon, J.B. Lipoff, M. Rosenbach, C. Kovarik, J. Takeshita, et al.
The American Academy of Dermatology COVID-19 Registry: crowdsourcing dermatology in the age of COVID-19.
J Am Acad Dermatol, (2020),
[3]
B. Joob, V. Wiwanitkit.
Chilblains-like Lesions and COVID-19.
Pediatr Dermatol, (2020),
[4]
M. El Hachem, A. Diociaiuti, C. Concato, R. Carsetti, C. Carnevale, M. Ciofi Degli Atti, et al.
A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
J Eur Acad Dermatol Venereol, (2020),

Please cite this article as: Wiwanitkit V. Chilblain y lesiones purpúricas acrales en COVID-19. Actas Dermosifiliogr. 2020;111:627.

Copyright © 2020. AEDV
Idiomas
Actas Dermo-Sifiliográficas (English Edition)

Subscribe to our newsletter

Article options
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
  • Additional material
Tools
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.